Assistant Professor, Surgery, Brown University Program in Medicine
Urology
Dr. Dragan J. Golijanin, MD
|
|
Give Review
Dragan J. Golijanin practices Urology. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Dragan Golijanin is a published MD. He has 53 publications published. The most current publication "Small-bowel pandiverticulosis--a potential source of recurrent gastrointestinal bleeding. Report of a case and review of the literature." Dragan J. Golijanin accepts all Medicare patients.
Publications
- Rectal Swab Culture-directed Antimicrobial Prophylaxis for Prostate Biopsy and Risk of Postprocedure Infection: A Cohort Study.
- Non-Bladder cancer mortality in patients with urothelial cancer of the Bladder.
- Analysis of a large single-center experience with robot-assisted pyeloplasty.
- Hand Assisted Laparoscopic vs Robotic Assisted Laparoscopic Partial Nephrectomy: Comparison of Short-term Outcomes and Cost.
- What's new in urologic ultrasound?
- Doppler evaluation of Erectile dysfunction - part 1.
- Doppler evaluation of Erectile dysfunction - part 2.
- Inducible microsomal prostaglandin E synthase is overexpressed in colorectal adenomas and Cancer.
- Laparoscopic vs open adRenalectomy for benign adRenal neoplasm.
- Is the pediatric ureter as efficient as the adult ureter in transporting fragments following extracorporeal shock wave lithotripsy for Renal calculi larger than 10 mm.?
- Inducible prostaglandin E synthase is overexpressed in non-small cell lung Cancer.
- Extracorporeal shock wave lithotripsy is highly effective for Ureteral calculi in children.
- Immunostaining of cytokeratin 20 in cells from voided urine for detection of Bladder cancer.
- Combined endoscopic and surgical management of Mirizzi syndrome.
- Small-bowel pandiverticulosis--a potential source of recurrent gastrointestinal bleeding. Report of a case and review of the literature.
- Selective ablation of immature Blood vessels in established human tumors follows vascular endothelial growth factor withdrawal.
- The supracostal percutaneous nephrostomy for treatment of staghorn and complex kidney Stones.
- Immunostaining of Lewis X in cells from voided urine, cytopathology and ultrasound for noninvasive detection of Bladder tumors.
- Resolution of posterior Urethral rupture caused by a gunshot injury, treated with only suprapubic drainage.
- Detection of Bladder tumors by immunostaining of the Lewis X antigen in cells from voided urine.
- Laparoscopic cholecystectomy in octogenarians.
- Transurethral incision of ureteroneocystostomy strictures in Kidney transplant recipients.
- Carcinoma in a Bladder diverticulum: presentation and treatment outcome.
- Outcome analysis of tunica vaginalis flap for the correction of recurrent urethrocutaneous fistula in children.
- Microsomal prostaglandin E synthase-1 is overexpressed in head and neck squamous cell carcinoma.
- Orthotopic urinary diversion after cystectomy for Bladder cancer: implications for cancer control and patterns of disease recurrence.
- Primary and postoperative retroperitoneal fibrosis-experience with 18 cases.
- Evaluation of urine CYFRA 21-1 for the detection of primary and recurrent Bladder carcinoma.
- Urothelial Cancer of the renal pelvis in percutaneous nephrolithotomy patients.
- Chemotherapy induces the expression of cyclooxygenase-2 in non-small cell lung Cancer.
- Laparoscopic nephrectomy for infected, obstructed and non-functioning Kidneys.
- Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma.
- Cyclooxygenase-2 and microsomal prostaglandin E synthase-1 are overexpressed in squamous cell carcinoma of the penis.
- Microsomal prostaglandin E synthase-1 is overexpressed in inflammatory bowel disease. Evidence for involvement of the transcription factor Egr-1.
- Robot-assisted radical Prostatectomy in obese patients.
- FK506 and Erectile function preservation in the cavernous nerve injury model: optimal dosing and timing.
- Patient-reported validated functional outcome after extraperitoneal robotic-assisted nerve-sparing radical Prostatectomy.
- Editorial comment on: Bladder and urethral sphincter function after radical retropubic prostatectomy: a prospective long-term study.
- Current state of screening for Bladder cancer.
- Impact of Prostate size in robot-assisted radical Prostatectomy.
- Adult genitoUrinary sarcoma: the 25-year Memorial Sloan-Kettering experience.
- Identifying additional lymph nodes in radical cystectomy lymphadenectomy specimens.
- The burden of Bladder cancer in men and women: analysis of the years of life lost.
- Neoadjuvant gemcitabine and cisplatin chemotherapy for locally advanced urothelial cancer of the Bladder.
- Near infrared fluorescence imaging with robotic assisted laparoscopic partial nephrectomy: initial clinical experience for Renal cortical tumors.
- The impact of robotics on treatment of localized prostate Cancer and resident education in Rochester, New York.
- Re: Dipstick pseudoHematuria: unnecessary consultation and evaluation. P. K. Rao, T. Gao, M. Pohl and J. S. Jones J Urol 2010; 183: 560-565.
- Long-term outcome of patients with a negative work-up for asymptomatic microHematuria.
- Treatment of nonmuscle invading Bladder cancer: do physicians in the United States practice evidence based medicine? The use and economic implications of intravesical ...
- Androgen deprivation therapy for advanced prostate Cancer: why does it fail and can its effects be prolonged?
- Sensitivity and specificity of 24-hour Urine chemistry levels for detecting elevated calcium oxalate and calcium phosphate supersaturation.
- Chemoprevention of Bladder cancer.
Procedures Preformed
- AdRenalectomy
- Complete Nephrectomy With Robotic Assistance
- Cystectomy
- Cystourethroscopy and TransUrethral Resection of Bladder Neck
- View All
Conditions Treated
- Bladder Cancer
- Bladder Infection
- Bladder Stones
- Blood in Urine (Hematuria)
- View All
Doctors Specialties
- Urology
Accepted Insurances
- Choice Plus POS II
- Blue Card PPO
- Blue Choice
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Emblem Health
- Fidelis Care HMO
- First Health (Coventry Health Care) PPO
- Harvard Pilgrim Health Care PPO
- Medicare Advantage PFFS
- Humana
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Neighborhood Health Plan
- Tufts Health Plans
- Tufts PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Rochester -
University of Belgrade Faculty of Medicine
Hospital
-
Rhode Island Hospital
Drug Facts
| NPI NUMBER | 1841304078 | |
| NPPES Provider LastName | GOLIJANIN | |
| NPPES Provider FirstName | DRAGAN | |
| NPPES Provider ZIPCode | 029053247 | |
| NPPES Provider State | RI | |
| Specialty Description | Urology | |
| Total Claim Count | 263.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 16.0 | |
| Percent Opioid Claims | 6.08 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1841304078 |
| Last Name Of The Provider | GOLIJANIN |
| First Name Of The Provider | DRAGAN |
| View All |
Similar Doctors
|
|
Dr. Kathleen Hwang, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arthur W. Wong, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Simone Thavaseelan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael Alavian, MD |
|
|
Dr. Shadi Al Ekish, MD |
|
|
Dr. George Turini, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Atip Chatsudthipong, MD |
|
|
Dr. Barry S. Stein, MD |
|
|
Dr. Mark Sigman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gyan Pareek, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Harry M. Iannotti, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anthony A. Caldamone, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|